Quest Diagnostics Reports Third Quarter 2017 Financial Results, Updates 2017 Financial Guidance and Reaffirms Long Term Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall as megacap tech drags; Iran developments watched
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Quest Diagnostics (DGX) PT Lowered to $103 at Mizuho Securities
October 19, 2017 5:19 PM EDTMizuho Securities lowered its price target on Quest Diagnostics (NYSE: DGX) to $103.00 (from $122.00) while maintaining a Buy rating. Analyst Ann Hynes updated 2018 and 2019 adjusted EPS estimates, both decreasing by $0.10 related to the proposed PAMA rule released in September.
Mizuho Securities did not... More
Quest Diagnostics (DGX) Tops Q3 EPS by 4c
October 19, 2017 6:48 AM EDTQuest Diagnostics (NYSE: DGX) reported Q3 EPS of $1.39, $0.04 better than the analyst estimate of $1.35. Revenue for the quarter came in at $1.93 billion versus the consensus estimate of $1.92 billion.
GUIDANCE:
Quest Diagnostics sees FY2017 EPS of $5.62-$5.67, versus the consensus of $5.63. Quest... More
